PTSD Trial, Recruiting NCT07283757 Sponsor: University of Wisconsin, Madison Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07283757
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • You are 18 years old or older
  • You are on the Department of Corrections trauma treatment waitlist
  • You have been assessed and do not currently have active symptoms of psychosis that would get in the way of taking part in group sessions
  • You do not currently have thoughts of suicide with a plan or intention to act on them
  • You are willing and able to take part in group therapy sessions
  • You have been assessed and currently meet the criteria for a PTSD diagnosis within the past 2 months before joining
  • Your scheduled release date is not before the treatment group would end
  • You are able to understand the consent form, as shown by completing a short quiz about it

Who may not be able to join:

  • You currently have active symptoms of psychosis that could interfere with your ability to participate in the group
  • You currently have thoughts of suicide with a plan or intent to act on them
  • You are unwilling or unable to take part in group therapy
  • Your release date is scheduled before the treatment program would be completed
  • You are unable to demonstrate understanding of the consent form through the consent quiz
  • You have previously taken part in a CPT (Cognitive Processing Therapy) group run by the UW project

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael R Koenigs, PhD, University of Wisconsin, Madison

Phone: (608) 263-1679

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 December 2025
Est. completion
1 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Conduct Reports

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov